Save the Date - more information to follow
Side 8 af 8
Ny professor ved Institut for Klinisk Medicin, Aarhus Universitet
Innovativ lægemiddel udvikling uden serendipitet - Er det muligt?
Prognosis in acute myeloid leukemia: Impact of time-to-treatment, non-hematological comorbidity, secondary and therapy-related leukemia.
Side 422 af 475